Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

61.28
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
53.63
Today|||52-Week Range
66.80
+8.90%
Year-to-Date
Cancer Space Update: Label Expansions, Data Readouts in Focus
Jan 19 / Zacks.com - Paid Partner Content
BioLineRx Cancer Drug Positive as Monotherapy in Phase IIa
Jan 18 / Zacks.com - Paid Partner Content
Will J&J's (JNJ) Pharma Segment Pull Up its Q4 Earnings?
Jan 19 / Zacks.com - Paid Partner Content
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?
Jan 18 / Zacks.com - Paid Partner Content
Here's Why Nektar Stock Skyrocketed Almost 500% in a Year
Jan 19 / Zacks.com - Paid Partner Content
Merck Strong on Confirmatory Phase III Lung Cancer Study
Jan 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah L...
Jan 19 / Zacks.com - Paid Partner Content
7 Stocks Move in Premarket Trade Wednesday
Jan 17 / GuruFocus News - Paid Partner Content
Jolley Asset Management, LLC Buys Merck Inc, Axalta Coating Systems, Roche Holding AG...
Jan 18 / GuruFocus News - Paid Partner Content
Juno's Stock High on Possible Acquisition
Jan 17 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close61.28
Today’s open61.48
Day’s range60.64 - 61.48
Volume12,161,865
Average volume (3 months)11,646,765
Market cap$167.1B
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+4.28%
Earnings growth (next 5 years)+4.30%
Revenue growth (last year)+1.86%
P/E ratio58.9
Price/Sales4.15
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
NVSNovartis0.000.00%
PFEPfizer0.000.00%
SNYSanofi0.000.00%
ABBVAbbVie0.000.00%
Data as of 4:02pm ET, 01/19/2018

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$0.94
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts